Cargando…
Ga(III) pyridinecarboxylate complexes: potential analogues of the second generation of therapeutic Ga(III) complexes?
A series of novel Ga(III)—pyridine carboxylates ([Ga(Pic)(3)]·H(2)O (GaPic; HPic = picolinic acid), H(3)O[Ga(Dpic)(2)]·H(2)O (GaDpic; H(2)Dpic = dipicolinic acid), [Ga(Chel)(H(2)O)(OH)](2)·4H(2)O (GaChel; H(2)Chel = chelidamic acid) and [Ga(Cldpic)(H(2)O)(OH)](2) (GaCldpic; H(2)Cldpic = 4-chlorodipi...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415494/ https://www.ncbi.nlm.nih.gov/pubmed/37498326 http://dx.doi.org/10.1007/s00775-023-02012-2 |
_version_ | 1785087552639729664 |
---|---|
author | Rendošová, Michaela Gyepes, Róbert Sovová, Simona Sabolová, Danica Vilková, Mária Olejníková, Petra Kello, Martin Lakatoš, Boris Vargová, Zuzana |
author_facet | Rendošová, Michaela Gyepes, Róbert Sovová, Simona Sabolová, Danica Vilková, Mária Olejníková, Petra Kello, Martin Lakatoš, Boris Vargová, Zuzana |
author_sort | Rendošová, Michaela |
collection | PubMed |
description | A series of novel Ga(III)—pyridine carboxylates ([Ga(Pic)(3)]·H(2)O (GaPic; HPic = picolinic acid), H(3)O[Ga(Dpic)(2)]·H(2)O (GaDpic; H(2)Dpic = dipicolinic acid), [Ga(Chel)(H(2)O)(OH)](2)·4H(2)O (GaChel; H(2)Chel = chelidamic acid) and [Ga(Cldpic)(H(2)O)(OH)](2) (GaCldpic; H(2)Cldpic = 4-chlorodipicolinic acid)) have been synthesized by simple one-step procedure. Vibrational spectroscopy (mid-IR), elemental analysis, thermogravimetric analysis and X-ray diffraction confirmed complexes molecular structure, inter and intramolecular interactions and their influence to spectral and thermal properties. Moreover, complex species speciation was described in Ga(III)-HPic and Ga(III)-H(2)Dpic systems by potentiometry and (1)H NMR spectroscopy and mononuclear complex species were determined; [Ga(Pic)(2)](+) (logβ(021) = 16.23(6)), [Ga(Pic)(3)] (logβ(031) = 20.86(2)), [Ga(Dpic)(2)](−) (logβ(021) = 15.42(9)) and [Ga(Dpic)(2)(OH)](2−) (logβ(-121) = 11.08(4)). To confirm the complexes stability in 1% DMSO (primary solvent for biological testing), timescale (1)H NMR spectra were measured (immediately after dissolution up to 96 h). Antimicrobial activity evaluated by IC(50) (0.05 mM) is significant for GaDpic and GaCldpic against difficult to treat and multi-resistant P. aeruginosa. On the other hand, the GaPic complex is most effective against Jurkat, MDA-MB-231 and A2058 cancer cell lines and significantly also decreases the HepG2 cancer cells viability at 75 and 100 μM concentrations in a relatively short time (up to 48 h). In addition, fluorescence measurements have been used to elucidate bovine serum albumin binding activity between ligands, Ga(III) complexes and bovine serum albumin. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00775-023-02012-2. |
format | Online Article Text |
id | pubmed-10415494 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-104154942023-08-12 Ga(III) pyridinecarboxylate complexes: potential analogues of the second generation of therapeutic Ga(III) complexes? Rendošová, Michaela Gyepes, Róbert Sovová, Simona Sabolová, Danica Vilková, Mária Olejníková, Petra Kello, Martin Lakatoš, Boris Vargová, Zuzana J Biol Inorg Chem Original Paper A series of novel Ga(III)—pyridine carboxylates ([Ga(Pic)(3)]·H(2)O (GaPic; HPic = picolinic acid), H(3)O[Ga(Dpic)(2)]·H(2)O (GaDpic; H(2)Dpic = dipicolinic acid), [Ga(Chel)(H(2)O)(OH)](2)·4H(2)O (GaChel; H(2)Chel = chelidamic acid) and [Ga(Cldpic)(H(2)O)(OH)](2) (GaCldpic; H(2)Cldpic = 4-chlorodipicolinic acid)) have been synthesized by simple one-step procedure. Vibrational spectroscopy (mid-IR), elemental analysis, thermogravimetric analysis and X-ray diffraction confirmed complexes molecular structure, inter and intramolecular interactions and their influence to spectral and thermal properties. Moreover, complex species speciation was described in Ga(III)-HPic and Ga(III)-H(2)Dpic systems by potentiometry and (1)H NMR spectroscopy and mononuclear complex species were determined; [Ga(Pic)(2)](+) (logβ(021) = 16.23(6)), [Ga(Pic)(3)] (logβ(031) = 20.86(2)), [Ga(Dpic)(2)](−) (logβ(021) = 15.42(9)) and [Ga(Dpic)(2)(OH)](2−) (logβ(-121) = 11.08(4)). To confirm the complexes stability in 1% DMSO (primary solvent for biological testing), timescale (1)H NMR spectra were measured (immediately after dissolution up to 96 h). Antimicrobial activity evaluated by IC(50) (0.05 mM) is significant for GaDpic and GaCldpic against difficult to treat and multi-resistant P. aeruginosa. On the other hand, the GaPic complex is most effective against Jurkat, MDA-MB-231 and A2058 cancer cell lines and significantly also decreases the HepG2 cancer cells viability at 75 and 100 μM concentrations in a relatively short time (up to 48 h). In addition, fluorescence measurements have been used to elucidate bovine serum albumin binding activity between ligands, Ga(III) complexes and bovine serum albumin. GRAPHICAL ABSTRACT: [Image: see text] SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s00775-023-02012-2. Springer International Publishing 2023-07-27 2023 /pmc/articles/PMC10415494/ /pubmed/37498326 http://dx.doi.org/10.1007/s00775-023-02012-2 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Original Paper Rendošová, Michaela Gyepes, Róbert Sovová, Simona Sabolová, Danica Vilková, Mária Olejníková, Petra Kello, Martin Lakatoš, Boris Vargová, Zuzana Ga(III) pyridinecarboxylate complexes: potential analogues of the second generation of therapeutic Ga(III) complexes? |
title | Ga(III) pyridinecarboxylate complexes: potential analogues of the second generation of therapeutic Ga(III) complexes? |
title_full | Ga(III) pyridinecarboxylate complexes: potential analogues of the second generation of therapeutic Ga(III) complexes? |
title_fullStr | Ga(III) pyridinecarboxylate complexes: potential analogues of the second generation of therapeutic Ga(III) complexes? |
title_full_unstemmed | Ga(III) pyridinecarboxylate complexes: potential analogues of the second generation of therapeutic Ga(III) complexes? |
title_short | Ga(III) pyridinecarboxylate complexes: potential analogues of the second generation of therapeutic Ga(III) complexes? |
title_sort | ga(iii) pyridinecarboxylate complexes: potential analogues of the second generation of therapeutic ga(iii) complexes? |
topic | Original Paper |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415494/ https://www.ncbi.nlm.nih.gov/pubmed/37498326 http://dx.doi.org/10.1007/s00775-023-02012-2 |
work_keys_str_mv | AT rendosovamichaela gaiiipyridinecarboxylatecomplexespotentialanaloguesofthesecondgenerationoftherapeuticgaiiicomplexes AT gyepesrobert gaiiipyridinecarboxylatecomplexespotentialanaloguesofthesecondgenerationoftherapeuticgaiiicomplexes AT sovovasimona gaiiipyridinecarboxylatecomplexespotentialanaloguesofthesecondgenerationoftherapeuticgaiiicomplexes AT sabolovadanica gaiiipyridinecarboxylatecomplexespotentialanaloguesofthesecondgenerationoftherapeuticgaiiicomplexes AT vilkovamaria gaiiipyridinecarboxylatecomplexespotentialanaloguesofthesecondgenerationoftherapeuticgaiiicomplexes AT olejnikovapetra gaiiipyridinecarboxylatecomplexespotentialanaloguesofthesecondgenerationoftherapeuticgaiiicomplexes AT kellomartin gaiiipyridinecarboxylatecomplexespotentialanaloguesofthesecondgenerationoftherapeuticgaiiicomplexes AT lakatosboris gaiiipyridinecarboxylatecomplexespotentialanaloguesofthesecondgenerationoftherapeuticgaiiicomplexes AT vargovazuzana gaiiipyridinecarboxylatecomplexespotentialanaloguesofthesecondgenerationoftherapeuticgaiiicomplexes |